V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014762 | 160007274 | 1.63 | 100.8 | Neo-adjuvant (N) | 2019-02-16 | 2019-02-24 | Doxorubicin + Ifosfamide | 02 | N | HYDROXYCARBAMIDE | 101589691 |
| 160014766 | 160007276 | 1.75 | 83 | Neo-adjuvant (N) | 2018-04-06 | 2018-04-20 | ETOPOSIDE + IFOSFAMIDE | 02 | null | DOXORUBICIN + OLARATUMAB | 101516849 |
| 160014767 | 160007277 | 1.79 | 106.4 | Curative (C) | 2016-09-08 | 2016-09-08 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100491236 |
| 160014768 | 160007278 | 1.94 | 100 | Palliative (P) | 2018-02-11 | 2018-02-20 | Doxorubicin + Ifosfamide | 02 | N | TRIAL | 100650592 |
| 160014769 | 160007279 | 1.68 | 52.2 | Palliative (P) | 2017-04-17 | 2017-04-18 | EP 1 2 or 3 day | 02 | N | LIPOSOMAL DOXORUBICIN | 100426511 |
| 160014770 | 160007280 | 1.8 | 101.4 | Neo-adjuvant (N) | null | 2019-08-14 | Trial Unspecified | 02 | N | CISPLATIN | 100794280 |
| 160014772 | 160007281 | null | null | null | 2017-06-11 | 2017-06-12 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100581547 |
| 160014773 | 160007282 | 1.62 | 63.8 | Curative (C) | 2017-05-26 | 2017-06-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100674951 |
| 160014775 | 160007283 | 1.75 | 77.7 | Palliative (P) | 2020-02-04 | 2020-02-05 | Cisplatin + Pemetrexed | 01 | N | CISPLATIN + PEMETREXED | 101296067 |
| 160014777 | 160007284 | 1.57 | 102.5 | Palliative (P) | 2016-07-30 | 2016-07-31 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101277769 |
| 160014779 | 160007285 | 1.74 | 90.7 | Palliative (P) | 2019-01-30 | 2019-02-20 | Liposomal Doxorubicin (Caelyx) | 02 | N | TRIAL | 100696816 |
| 160014780 | 160007286 | 1.69 | 92 | Adjuvant (A) | 2017-01-26 | 2017-01-29 | ETOP 13-18 BEAT-meso Trial | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100330010 |
| 160014781 | 160007287 | 1.75 | 103 | Palliative (P) | null | 2017-08-01 | MELPHALAN | 02 | null | RITUXIMAB | 100653361 |
| 160014782 | 160007288 | 1.79 | 81.8 | Palliative (P) | 2020-04-05 | 2020-04-28 | Cisplatin + Pemetrexed | N | N | ETOP 13-18 BEAT-MESO TRIAL | 100983182 |
| 160014783 | 160007289 | 1.7 | 58 | null | 2018-11-06 | 2018-11-06 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100972804 |
| 160014785 | 160007290 | 1.82 | 77 | Palliative (P) | null | 2018-12-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100694870 |
| 160014787 | 160007291 | 1.67 | 62 | Palliative (P) | 2016-08-22 | 2016-08-31 | Doxorubicin 75mg/m2 | N | N | DOXORUBICIN | 101638444 |
| 160014788 | 160007292 | 1.5 | 20 | Adjuvant (A) | 2016-10-30 | 2016-11-19 | ETOPOSIDE + RITUXIMAB | 02 | N | PEMETREXED | 101840982 |
| 160014792 | 160007293 | 1.56 | 99.95 | Palliative (P) | 2019-06-04 | 2019-06-19 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100125038 |
| 160014797 | 160007294 | 1.66 | 53.4 | Palliative (P) | 2018-11-26 | 2018-12-03 | Liposomal Doxorubicin (Caelyx) | N | N | IMATINIB | 100168691 |
| 160014798 | 160007295 | 1.73 | 93.1 | Neo-adjuvant (N) | 2018-07-23 | 2018-07-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101328497 |
| 160014801 | 160007296 | 1.73 | 129.1 | Palliative (P) | 2018-03-25 | 2018-04-12 | Cisplatin + Pemetrexed | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101166460 |
| 160014802 | 160007297 | 1.71 | 99 | Neo-adjuvant (N) | 2017-06-20 | 2017-07-02 | Pemetrexed + CISPLATIN | 02 | N | CISPLATIN + PEMETREXED | 100366365 |
| 160014803 | 160007298 | 1.58 | 61.5 | Palliative (P) | 2016-10-08 | 2016-10-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100225686 |
| 160014804 | 160007299 | null | null | null | 2018-05-13 | 2018-05-15 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100494399 |
| 160014805 | 160007300 | 1.78 | 97 | Palliative (P) | 2020-11-26 | 2020-12-14 | null | 02 | N | BEVACIZUMAB | 101441226 |
| 160014806 | 160007301 | 1.76 | 94.4 | Palliative (P) | null | 2018-04-02 | Cisplatin + Paclitaxel | 02 | N | GC INT GUIDE EXCRANIAL GERMCELL JEB | 100621135 |
| 160014807 | 160007302 | 1.77 | 77.4 | Curative (C) | 2019-12-12 | 2019-12-16 | null | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100724141 |
| 160014808 | 160007303 | 1.58 | 70 | Palliative (P) | 2019-06-25 | 2019-07-22 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100916509 |
| 160014810 | 160007304 | 1.8 | 75 | Palliative (P) | 2018-01-31 | 2018-02-13 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100467731 |
| 160014811 | 160007305 | 1.69 | 71.85 | Curative (C) | 2016-02-12 | 2016-02-25 | VIDE | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100126276 |
| 160014812 | 160007306 | 1.84 | 79.9 | Palliative (P) | 2016-09-04 | 2016-09-04 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101659167 |
| 160014816 | 160007308 | 1.73 | 75 | Palliative (P) | 2019-10-02 | 2019-10-30 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100241575 |
| 160014817 | 160007309 | 1.59 | 62.3 | Curative (C) | null | 2018-11-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100897515 |
| 160014818 | 160007310 | 1.88 | 75 | Palliative (P) | 2016-10-14 | 2016-10-15 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100979121 |
| 160014821 | 160007311 | 1.71 | 77 | Palliative (P) | 2017-07-06 | 2017-07-14 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101055623 |
| 160014822 | 160007312 | 1.52 | 79 | Palliative (P) | 2017-04-23 | 2017-04-30 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100059967 |
| 160014823 | 160007313 | 1.83 | 83.7 | Curative (C) | 2019-04-03 | 2019-04-10 | DACARBAZINE + DOXORUBICIN | 02 | N | VINCRISTINE | 100298661 |
| 160014824 | 160007314 | 1.82 | 62.4 | Palliative (P) | 2019-08-04 | 2019-08-10 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | DOXORUBICIN | 100884196 |
| 160014825 | 160007315 | 1.74 | 66.2 | Curative (C) | 2016-12-30 | 2017-01-05 | DOXORUBICIN + IFOSFAMIDE | 01 | N | EW EUROEWING 2012 ARM A VAI | 100289358 |
| 160014827 | 160007316 | 1.48 | 76.6 | Palliative (P) | 2016-07-21 | 2016-07-26 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100715484 |
| 160014828 | 160007317 | 1.78 | 70 | Palliative (P) | 2016-06-01 | 2016-06-15 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100193688 |
| 160014829 | 160007318 | 1.56 | 51.4 | Neo-adjuvant (N) | 2016-09-12 | 2016-09-20 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100141147 |
| 160014831 | 160007319 | 1.84 | 69.2 | Neo-adjuvant (N) | 2020-02-08 | 2020-02-17 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101833929 |
| 160014836 | 160007320 | 1.8 | 65.1 | Palliative (P) | 2017-06-08 | 2017-06-22 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100354506 |
| 160014839 | 160007321 | 1.68 | 95 | Adjuvant (A) | null | 2015-05-15 | Doxorubicin + Ifosfamide | 02 | N | PACLITAXEL | 101395670 |
| 160014840 | 160007322 | 1.56 | 65.2 | Palliative (P) | 2019-02-22 | 2019-02-22 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CARBOPLATIN + PACLITAXEL | 100428462 |
| 160014841 | 160007323 | 1.76 | 70 | Neo-adjuvant (N) | 2017-06-15 | 2017-06-23 | Paclitaxel 7 day | N | N | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 100768747 |
| 160014842 | 160007324 | 1.56 | 117.5 | Palliative (P) | 2018-04-15 | 2018-04-19 | Bevacizumab | 02 | N | DOXORUBICIN | 100812838 |
| 160014845 | 160007325 | 1.93 | 70 | Neo-adjuvant (N) | 2019-02-24 | 2019-02-27 | Docetaxel+Gemcitabine (no prior RT) | 02 | Y | CYCLOPHOSPHAMIDE | 100169298 |